Yonghe Medical Group (2279) Releases Board Diversity Policy

Bulletin Express2025-10-28

Yonghe Medical Group Co., Ltd. (2279) detailed a newly adopted Board Diversity Policy, focusing on the benefits of having directors with varied skills, regional and industry experience, backgrounds, gender, and other qualities. According to the announcement, board appointments adhere to merit-based selection, with consideration of factors such as professional experience, educational background, independence, age, and gender.

The policy highlights an annual review process by the Nomination Committee, which evaluates the structure, size, and composition of the board and makes suggestions in line with the company’s strategy. The final decision on any board changes will be based on each individual’s comprehensive contribution. It is explicitly stated that the board will not consist of directors of a single gender.

The Nomination Committee will monitor and report on the board’s composition and oversee policy implementation. If specific measurable diversity objectives are established, the progress toward meeting those objectives will be disclosed in the corporate governance report within the company’s annual report. This policy is scheduled to take effect on October 28, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment